Alnylam Pharmaceuticals
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a global commercial-stage biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. Its products include ONPATTRO, GIVLAARI, and OXLUMO.
CEOYvonne L. Greenstreet
CEOYvonne L. Greenstreet
Employees2,002
Employees2,002
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2002
Founded2002
Employees2,002
Employees2,002
ALNY Key Statistics
Market cap21.62B
Market cap21.62B
Price-Earnings ratio-20.05
Price-Earnings ratio-20.05
Dividend yield—
Dividend yield—
Average volume593.58K
Average volume593.58K
High today$179.77
High today$179.77
Low today$172.51
Low today$172.51
Open price$178.17
Open price$178.17
Volume558.01K
Volume558.01K
52 Week high$242.97
52 Week high$242.97
52 Week low$168.65
52 Week low$168.65
ALNY News
Benzinga 2d
Antisense Therapy Market | Alnylam Pharmaceuticals, Arbutus ... - BenzingaThe global antisense therapy market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the antisense...
Benzinga 4d
Analyst Expectations for Alnylam Pharmaceuticals's Future - Alnylam Pharmaceuticals - BenzingaOver the past 3 months, 20 analysts have published their opinion on Alnylam Pharmaceuticals ALNY stock. These analysts are typically employed by large Wall Stre...
Analyst ratings
79%
of 28 ratingsBuy
78.6%
Hold
21.4%
Sell
0%
ALNY Earnings
-$2.03
-$1.35
-$0.68
$0.00
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Q2 FY23
Q3 FY23
Estimated-$1.44 per share
Estimated-$1.44 per share
ActualExpected Nov 2, Pre-Market
ActualExpected Nov 2, Pre-Market